Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 381 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALLTojo, A.; Usuki, K.; Urabe, A.; Maeda, Y.; Kobayashi, Y.; Jinnai, I.; Ohyashiki, K.; Nishimura, M.; Kawaguchi, T.; Tanaka, H.; Miyamura, K.; Miyazaki, Y.; Hughes, T.; Branford, S.; Okamoto, S.; Ishikawa, J.; Okada, M.; Usui, N.; Tanii, H.; Amagasaki, T.; et al.
2004Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaMollee, P.; Arthur, C.; Hughes, T.; Januszewicz, H.; Grigg, A.; Bradstock, K.; Wolf, M.; Gibson, J.; Schwarer, A.; Spencer, A.; Browett, P.; Hawkins, T.; Seldon, M.; Herrmann, R.; Watson, A.; Seymour, J.; Martin, N.; Shina, S.; Low, C.; Wright, S.; et al.
2010Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trialCastro, M.; Rubin, A.; Laviolette, M.; Fiterman, J.; Lima, M.; Shah, P.; Fiss, E.; Olivenstein, R.; Thomson, N.; Niven, R.; Pavord, I.; Simoff, M.; Duhamel, D.; McEvoy, C.; Barbers, R.; ten Hacken, N.; Wechsler, M.; Holmes, M.; Phillips, M.; Erzurum, S.; et al.
2012Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureKazenwadel, J.; Secker, G.; Liu, Y.; Rosenfeld, J.; Wildin, R.; Cuellar-Rodriguez, J.; Hsu, A.; Dyack, S.; Fernandez, C.; Chong, C.; Babic, M.; Bardy, P.; Shimamura, A.; Zhang, M.; Walsh, T.; Holland, S.; Hickstein, D.; Horwitz, M.; Hahn, C.; Scott, H.; et al.
2010Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaLamprecht, B.; Walter, K.; Kreher, S.; Kumar, R.; Hummel, M.; Lenze, D.; Kochert, K.; Bouhlel, M.; Richter, J.; Soler, E.; Stadhouders, R.; Johrens, K.; Wurster, K.; Callen, D.; Harte, M.; Giefing, M.; Barlow, R.; Stein, H.; Anagnostopoulos, I.; Janz, M.; et al.
2013A genome-wide association study for malignant mesothelioma riskCadby, G.; Mukherjee, S.; Musk, A.; Reid, A.; Garlepp, M.; Dick, I.; Robinson, C.; Hui, J.; Fiorito, G.; Guarrera, S.; Beilby, J.; Melton, P.; Moses, E.; Ugolini, D.; Mirabelli, D.; Bonassi, S.; Magnani, C.; Dianzani, I.; Matullo, G.; Robinson, B.; et al.
2010Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meetingParkman, H.; Camilleri, M.; Farrugia, G.; McCallum, R.; Bharucha, A.; Mayer, E.; Tack, J.; Spiller, R.; Horowitz, M.; Vinik, A.; Galligan, J.; Pasricha, P.; Kuo, B.; Szarka, L.; Marciani, L.; Jones, K.; Parrish, C.; Sandroni, P.; Abell, T.; Ordog, T.; et al.
2012Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trialKondalsamy-Chennakesavan, S.; Janda, M.; Gebski, V.; Baker, J.; Brand, A.; Hogg, R.; Jobling, T.W.; Land, R.; Manolitsas, T.; Nascimento, M.; Neesham, D.; Nicklin, J.L.; Oehler, M.K.; Otton, G.; Perrin, L.; Salfinger, S.; Hammond, I.; Leung, Y.; Sykes, P.; Ngan, H.; et al.
2003Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaO'Brien, S.; Guilhot, F.; Larson, R.; Gathmann, I.; Baccarani, M.; Cervantes, F.; Cornelissen, J.; Fischer, T.; Hochhaus, A.; Hughes, T.; Lechner, K.; Nielsen, J.; Rousselot, P.; Reiffers, J.; Saglio, G.; Shepherd, J.; Simonsson, B.; Gratwohl, A.; Goldman, J.; Kantarjian, H.; et al.
2003Autologous stem cell transplantation in multiple myelomy patients <60 vs ≥60 years of ageReece, D.; Bredeson, C.; Perez, W.; Jagannath, S.; Zhang, M.; Ballen, K.; Elfenbein, G.; Freytes, C.; Gale, R.; Gertz, M.; Gibson, J.; Giralt, S.; Keating, A.; Kyle, R.; Maharaj, D.; Marcellus, D.; McCarthy, P.; Milone, G.; Nimer, S.; Pavlovsky, S.; et al.